Page 2 - Sd Pharma News Today

4D Pharma announces positive results in asthma treatment trials | Financial News

Pancreatic Cancer Pipeline is enriched with novel therapeutic strategies, including a broad range of therapies targeting diverse biologic processes. The...

Asthma is considered to be one of the world's most common diseases affecting the population, and is also a life-threatening condition affecting patients'...

Share this article Share this article ResearchAndMarkets.coms offering. This report profiles companies actively involved in developing microbiome therapeutics. Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The natural...

Press release content from Business Wire. The AP news staff was not involved in its creation. Global Human Microbiome Therapeutics Market Outlook to 2027, By Product, Therapeutic Area, Indication, Approach and Region - ResearchAndMarkets.com April 27, 2021 GMT DUBLIN--(BUSINESS WIRE)--Apr 27, 2021-- ADVERTISEMENT The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and s...

TRADING UPDATES: Ceres Power eyes move to Main Market by mid-2022 Wed, 17th Mar 2021 18:40 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Ceres Power Holdings PLC - Horsham, West Sussex-based solid oxide fuel cell developer - Proposes placing and subscription to raise GBP180m million via PrimaryBid. Says the net proceeds will be used to accelerate its investment in the development and potenti...

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma Mon, 1st Mar 2021 16:41 (Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-execu...

/PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS...

Investegate announcements from 4d Pharma PLC, Holding(s) in Company

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug | Financial News